Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Burkitt Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Biphenotypic, Acute 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Down Syndrome 3Osteosarcoma 2Lymphoma, Mantle-Cell 2Urothelial Carcinoma of the Bladder 1Sarcoma, Ewing 1Rhabdoid Tumor 1Renal Pelvis and Ureter Urothelial Carcinoma 1Oropharyngeal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Muscle Invasive Bladder Urothelial Carcinoma 1Mouth Neoplasms 1Meningeal Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Mast-Cell 1Leukemia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1GATA2 Deficiency 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma 1

Interventions

fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Specimen Handling 1Methotrexate 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
GATA2 Deficiency × Methotrexate × 30 days × Clear all
NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡